Notably, along with NOXA upregulation, the repression of the anti-apoptotic MCL-1 protein was always accompanied by a series of experiments when AML cells were treated with VEN plus VK2 (Figs 3, 4, and 6). The gene discussed is MCL1; the disease is acute myeloid leukemia.